| Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia. (NCT06356922) | Nantes University Hospital | 2024-10-22 |
| Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT06401980) | Swiss Cancer Institute | 2024-10-22 |
| Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) (NCT06329570) | NaviFUS Corporation | 2024-10-22 |
| Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma (NCT06583083) | Sun Yat-sen University | 2024-10-22 |
| A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia (NCT06651567) | Intra-Cellular Therapies, Inc. | 2024-10-22 |
| A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma (NCT06637254) | Haisco Pharmaceutical Group Co., Ltd. | 2024-10-22 |
| A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma (NCT06716853) | Genenta Science | 2024-10-22 |
| Combined THC and CBD for OUD and Chronic Pain (NCT06544291) | Yale University | 2024-10-22 |
| Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients (NCT06461546) | Fundacion Clinic per a la Recerca Biomédica | 2024-10-22 |
| QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia (NCT06456528) | Qilu Pharmaceutical Co., Ltd. | 2024-10-22 |
| Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia (NCT06648889) | Goethe University | 2024-10-22 |
| Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety (NCT06816667) | Biomind Labs Inc. | 2024-10-21 |
| Lesion Network MApping Navigated Continuous Theta-burst STimulation for Motor REcovery in Acute Ischemic Stroke (NCT06400407) | Beijing Tiantan Hospital | 2024-10-21 |
| Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies (NCT06648785) | University of Vermont Medical Center | 2024-10-21 |
| Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer (NCT06649331) | Fudan University | 2024-10-21 |
| Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas (NCT06557889) | Institut Claudius Regaud | 2024-10-21 |
| A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight (NCT06643728) | Eli Lilly and Company | 2024-10-21 |
| Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL (NCT06651853) | The First Affiliated Hospital of Xiamen University | 2024-10-21 |
| ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS) (NCT06430385) | Ionis Pharmaceuticals, Inc. | 2024-10-21 |
| Leniolisib for Immune Dysregulation in PIDs (NCT06549114) | Pharming Technologies B.V. | 2024-10-21 |
| Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients (NCT07221370) | Riverside University Health System Medical Center | 2024-10-21 |
| Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated (NCT06613685) | Gilead Sciences | 2024-10-21 |
| Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections (NCT06549530) | Bavarian Nordic | 2024-10-21 |
| Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis (NCT06450886) | Abcuro, Inc. | 2024-10-21 |
| A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature (NCT06382155) | BioMarin Pharmaceutical | 2024-10-21 |
| A Clinical Trial With KJ103 in Anti-GBM Disease (NCT06607016) | Shanghai Bao Pharmaceuticals Co., Ltd. | 2024-10-21 |
| Efficacy of Mazdutide for Treating PCOS (NCT06519656) | Shanghai Zhongshan Hospital | 2024-10-21 |
| Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis (NCT07612280) | Jubilant Therapeutics Inc. | 2024-10-21 |
| Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients (NCT06730009) | Medigen Biotechnology Corporation | 2024-10-21 |
| A Multi-center Evaluation of Aldafermin in a Randomized, Double-blind, Placebo-controlled Study in Subjects With Primary Sclerosing Cholangitis. (NCT06654726) | NGM Biopharmaceuticals, Inc | 2024-10-21 |
| Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea (NCT06257394) | Hyoung Jin Kang | 2024-10-20 |
| Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection (NCT06585020) | Centre Hospitalier Universitaire, Amiens | 2024-10-20 |
| PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease (NCT06861478) | Universidad Autonoma de Nuevo Leon | 2024-10-20 |
| TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas (NCT06640582) | Essen Biotech | 2024-10-20 |
| Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers (NCT06626139) | Robin Carhart-Harris, PhD, MA | 2024-10-20 |
| The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy (NCT06614985) | Renmin Hospital of Wuhan University | 2024-10-20 |
| An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy (NCT06288230) | Lantu Biopharma | 2024-10-20 |
| Efficacy of Locally Delivered Rosemary Extract Gel in Management of Periodontitis (NCT06601608) | Ain Shams University | 2024-10-20 |
| Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients . (NCT06632522) | Beijing Tsinghua Chang Gung Hospital | 2024-10-20 |
| Efficacy of Fecal Microbiota Transplantation in ICU Patients With Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance (NCT06603883) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-10-19 |
| Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL) (NCT05833724) | Great Novel Therapeutics Biotech & Medicals Corporation | 2024-10-18 |
| Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy (NCT06619860) | Vertex Pharmaceuticals Incorporated | 2024-10-18 |
| Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients (NCT07709013) | Tata Memorial Centre | 2024-10-18 |
| A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction (NCT06782594) | Shandong New Time Pharmaceutical Co., LTD | 2024-10-18 |
| First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) (NCT06730373) | Qilu Hospital of Shandong University | 2024-10-17 |
| A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China (NCT06640049) | GlaxoSmithKline | 2024-10-17 |
| Vaginal Photobiomodulation for Chronic Pelvic Pain (NCT06673108) | SoLa Pelvic Therapy | 2024-10-17 |
| A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD ) (NCT06559176) | Prime Medicine, Inc. | 2024-10-17 |
| A Study of BL-B01D1 in Patients With Recurrent Glioblastoma (NCT06598787) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-10-17 |
| Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program (NCT06253637) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2024-10-17 |
| IC14 for Treatment of Acute Decompensated Heart Failure (NCT06556810) | Implicit Bioscience | 2024-10-17 |
| Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation. (NCT07274761) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-10-17 |
| Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL (NCT06742515) | First Affiliated Hospital of Zhejiang University | 2024-10-17 |
| Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus (NCT06585514) | Beijing GoBroad Hospital | 2024-10-17 |
| Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD) (NCT06597942) | University of California, Los Angeles | 2024-10-17 |
| Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body (NCT06645691) | National Heart Centre Singapore | 2024-10-17 |
| Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache (NCT06621329) | University of California, Davis | 2024-10-17 |
| A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) (NCT06643481) | Novartis Pharmaceuticals | 2024-10-17 |
| Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia (NCT06842966) | Valenta Pharm JSC | 2024-10-17 |
| Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa) (NCT06663176) | Thirty Respiratory Limited | 2024-10-16 |
| A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis (NCT06055959) | UCB Biopharma SRL | 2024-10-16 |
| A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery (NCT06662097) | Alume Biosciences, Inc. | 2024-10-16 |
| Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer (NCT06802666) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-10-16 |
| A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis (NCT06598462) | Uniquity One (UNI) | 2024-10-16 |
| A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for SCLC (NCT06478043) | Zhejiang Cancer Hospital | 2024-10-16 |
| A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine (NCT06581575) | Immorna Biotherapeutics, Inc. | 2024-10-16 |
| Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease (NCT06572267) | Xijing Hospital | 2024-10-16 |
| Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill (NCT06597058) | Noah Pharmaceuticals, Inc. | 2024-10-16 |
| Personalized Pharmaconutrition Therapy for Myosteatosis, Sarcopenia, and Prognosis in Gastric Cancer Patients (NCT07466758) | Biruni University | 2024-10-16 |
| Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer (NCT06766019) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-16 |
| A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies (NCT06815965) | EIP Pharma Inc | 2024-10-16 |
| Study of ASN51 in Adults With Early Alzheimer's Disease (NCT06677203) | Asceneuron S.A. | 2024-10-16 |
| RTX001 Autologous Engineered Macrophages for Liver Cirrhosis (NCT06823713) | Resolution Therapeutics Limited | 2024-10-15 |
| Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy (NCT06589089) | Ruijin Hospital | 2024-10-15 |
| Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency (NCT07115082) | Yan Hongli | 2024-10-15 |
| Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14) (NCT06629818) | Peking Union Medical College Hospital | 2024-10-15 |
| The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study (NCT06504420) | Peking University People's Hospital | 2024-10-15 |
| A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of Oral Teslanbaicin in Patients With Radiation Proctitis (NCT06974123) | The First Affiliated Hospital of Xinxiang Medical College | 2024-10-15 |
| Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder (NCT06605599) | AbbVie | 2024-10-15 |
| A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study (NCT06410209) | Children's Oncology Group | 2024-10-15 |
| Nasal Obstruction With Oxymetazoline and Corticosteroids (NCT06830109) | Washington University School of Medicine | 2024-10-15 |
| Effects of Synbiotics on Obesity (NCT06578143) | Leeuwenhoek Laboratories Co. Ltd. | 2024-10-15 |
| Vitamin D Supplementation in Breast Cancer Patients (NCT06596122) | Abdelrahman Mahmoud | 2024-10-15 |
| Maitake for Integrative Cancer Care (NCT06323473) | The Canadian College of Naturopathic Medicine | 2024-10-15 |
| Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT (NCT06664996) | West China Hospital | 2024-10-15 |
| Comparison of Ultrasound-Guided Subacromial vs. Systemic Steroid Injections for Frozen Shoulder: a Multicenter Pilot Study (NCT06626568) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-10-15 |
| Study of ATX-01 in Participants With DM1 (NCT06300307) | ARTHEx Biotech S.L. | 2024-10-15 |
| To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia (NCT06622824) | Suzhou Kintor Pharmaceutical Inc, | 2024-10-15 |
| A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer (NCT06327490) | University of Florida | 2024-10-15 |
| Mucoadhesive Film With/without Acmella Oleracea & Triamcinolone Acetonide for Aphthous Ulcers (NCT06622213) | Khon Kaen University | 2024-10-15 |
| The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain (NCT06637527) | Okyo Pharma Ltd | 2024-10-15 |
| Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia (NCT06629324) | Vinmec Research Institute of Stem Cell and Gene Technology | 2024-10-15 |
| HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer (NCT06709885) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2024-10-15 |
| Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder (NCT06545916) | Knoa Pharma LLC | 2024-10-14 |
| Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis (CRS). (NCT07184684) | Region Skane | 2024-10-14 |
| A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma (NCT06668987) | Heron Neutron Medical Corp. | 2024-10-14 |
| Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer (NCT06547736) | Fudan University | 2024-10-14 |
| Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal Women (NCT06789900) | Odense University Hospital | 2024-10-14 |
| Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours (NCT06345079) | Australasian Gastro-Intestinal Trials Group | 2024-10-14 |
| The Clostridioides Difficile Trial of REC-3964 (NCT06536465) | Recursion Pharmaceuticals Inc. | 2024-10-14 |